Impact of intravenous exenatide infusion for perioperative blood glucose control on myocardial ischemia-reperfusion injuries after coronary artery bypass graft surgery: sub study of the phase II/III ExSTRESS randomized trial

BACKGROUND: The aim of the study was to investigate whether intravenous (iv) infusion of exenatide, a synthetic GLP-1 receptor agonist, could provide a protective effect against myocardial ischemia-reperfusion injury after coronary artery bypass graft (CABG) surgery. METHODS: A sub study analysis of...

Descripción completa

Detalles Bibliográficos
Autores principales: Besch, Guillaume, Perrotti, Andrea, Salomon du Mont, Lucie, Puyraveau, Marc, Ben-Said, Xavier, Baltres, Maude, Barrucand, Benoit, Flicoteaux, Guillaume, Vettoretti, Lucie, Samain, Emmanuel, Chocron, Sidney, Pili-Floury, Sebastien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211400/
https://www.ncbi.nlm.nih.gov/pubmed/30384842
http://dx.doi.org/10.1186/s12933-018-0784-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211400/
https://www.ncbi.nlm.nih.gov/pubmed/30384842
http://dx.doi.org/10.1186/s12933-018-0784-y

Ejemplares similares